FCX-007 / Precigen, Paragon Biosci  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
FCX-007 / Precigen, Paragon Biosci
DEFI-RDEB, NCT04213261: A Study of FCX-007 for Recessive Dystrophic Epidermolysis Bullosa

Active, not recruiting
3
6
US
FCX-007 (dabocemagene autoficel; see below for FCX-007 description)
Castle Creek Biosciences, LLC.
Recessive Dystrophic Epidermolysis Bullosa
01/23
07/37

Download Options